undamentalytics Newsletter

Caredx, Inc. income statement

In fiscal 2025, Caredx, Inc. reported revenue of $380m, up 13.8% on the year before, operating income of −$30.8m (a -8.1% margin) and net income of −$21.4m, or −$0.40 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Caredx, Inc.: income statement, annual
Fiscal year2012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Revenue20222728414877127192296322280334380497
Cost of revenue—————213345———————
Gross profit—————274482———————
Research and development53491212153149779082737184
Selling and marketing5668111322395477968482103126
General and administrative55812212023374975100119125108138
Operating income−2−11−12−37−20−16−25−23−30−77−20341−31116
Interest expense1——————————————
Net interest income−3−2−2−2−2——————————
Income before tax−5−4−1−14−41−57−48−24−20−32−76−19053−21124
Income tax00−20−2−2−1−2−1−10000−4
Net income−5−41−14−39−55−47−22−19−31−77−19053−21129
Diluted EPS−$5.01−$3.50$0.10−$1.16−$2.39−$2.38−$1.31−$0.52−$0.40−$0.59−$1.44−$3.54$0.93−$0.40$2.43
Diluted shares (average)1m1m9m12m16m23m36m42m46m52m53m54m57m53m53m
EBITDA−1−02−11−34−17−11−19−16−21−66−18955−16134

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: CDNA vs STLNCDNA vs USPHCDNA vs VMD

More: Health Care Services stocks compared, Health Care sector, rankings of US companies

Figures from Caredx, Inc.'s SEC filings (10-K and 10-Q), retrieved October 30, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Caredx, Inc.